BBC NEWS Americas Africa Europe Middle East South Asia Asia Pacific Arabic Spanish Russian Chinese Welsh
BBCi CATEGORIES   TV   RADIO   COMMUNICATE   WHERE I LIVE   INDEX    SEARCH 

BBC NEWS
 You are in:  Sci/Tech
Front Page 
World 
UK 
UK Politics 
Business 
Sci/Tech 
Health 
Education 
Entertainment 
Talking Point 
In Depth 
AudioVideo 


Commonwealth Games 2002

BBC Sport

BBC Weather

SERVICES 
Monday, 11 March, 2002, 12:44 GMT
Cloning fix for lab mice
Mice, BBC
The genetic defect had to be corrected in the stem cells
US scientists have managed to partially repair the faulty immune systems of sick mice using therapeutic cloning.

It is claimed to be the first demonstration from start to finish in an animal model of how the controversial technique might be used in humans.


This really is a tremendous confluence of very, very challenging technology

Dr George Daley
Embryo clones of the mice were created in the lab and their stem cells harvested and modified to correct the genetic defect that had led to the immune problem in the first place.

The stem cells were then injected back into the mice, where they improved the health of the animals.

"This really is a tremendous confluence of very, very challenging technology, wrapping them all together into a model therapy," said Dr George Daley, from The Whitehead Institute for Biomedical Research in Cambridge, Massachusetts, US. "We are the first to do this all the way."

The research has been published in the journal Cell.

Tail skin

The Whitehead research comes as news reports from China say scientists there have successfully extracted stem cells from human embryo clones.

Cell, Cell
The Whitehead research is published in the journal Cell
Many researchers hope the cloning procedure demonstrated in the Massachusetts rodents could pave the way for similar therapies in humans to treat diseases such as muscular dystrophy and Parkinson's.

The Whitehead team worked on mice with a severe immune deficiency resulting from the absence of a working Rag 2 gene. The genetic defect prevented the rodents from manufacturing antibodies to fight off disease.

First, the team made embryo clones of the mice by injecting their genetic code, extracted from skin cells on their tails, into mouse eggs that had been emptied of their nuclear DNA.

The clones were then allowed to develop until they could be mined for their embryonic stem cells, the "master cells" that have the ability to become virtually any type of cell in the body.

Journal restriction

The scientists added a working Rag 2 gene to the stem cells and a HoxB4 gene that drove the cells into becoming effective immune cells.

The goal was to give the mice stem cells that would make healthy blood cells. The process worked - to an extent.

Disease fighting cells known as B cells and T cells ordinarily make up about 40% of the animals' blood. After the experiment, they comprised about 3%.

"That was still enough to generate antibodies in these mice," Dr Daley said. "We would expect this level of reconstitution would provide significant immune function and have significant benefit."

Professor Lu Guangxiu, from the Xiangya Medical College in Changsa, China was unable to talk about her cloning work to the BBC on Monday.

She said an agreement had been reached with an international journal to publish her team's work and she was not allowed to speak to the media until the research paper appeared.

See also:

11 Feb 02 | Sci/Tech
Fresh warning over cloning dangers
04 Jan 02 | Sci/Tech
Dolly's arthritis sparks cloning row
Internet links:


The BBC is not responsible for the content of external internet sites

Links to more Sci/Tech stories are at the foot of the page.


E-mail this story to a friend

Links to more Sci/Tech stories